NO965260L - Benzopyraner og deres anvendelse som terapeutiske midler - Google Patents

Benzopyraner og deres anvendelse som terapeutiske midler

Info

Publication number
NO965260L
NO965260L NO965260A NO965260A NO965260L NO 965260 L NO965260 L NO 965260L NO 965260 A NO965260 A NO 965260A NO 965260 A NO965260 A NO 965260A NO 965260 L NO965260 L NO 965260L
Authority
NO
Norway
Prior art keywords
benzopyrans
therapeutic agents
therapeutic
agents
Prior art date
Application number
NO965260A
Other languages
English (en)
Other versions
NO965260D0 (no
NO315651B1 (no
Inventor
Wai Ngor Chan
Helen Kate Ann Morgan
Mervyn Thompson
John Morris Evans
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9411632A external-priority patent/GB9411632D0/en
Priority claimed from GB9411798A external-priority patent/GB9411798D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO965260D0 publication Critical patent/NO965260D0/no
Publication of NO965260L publication Critical patent/NO965260L/no
Publication of NO315651B1 publication Critical patent/NO315651B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/68—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with nitrogen atoms directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
NO19965260A 1994-06-10 1996-12-09 Benzopyraner, farmasöytiske preparater inneholdende disse og deres anvendelse som terapeutiske midler NO315651B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9411632A GB9411632D0 (en) 1994-06-10 1994-06-10 Novel treatment
GB9411798A GB9411798D0 (en) 1994-06-13 1994-06-13 Novel treatment
PCT/EP1995/002076 WO1995034545A1 (en) 1994-06-10 1995-05-31 Benzopyrans and their use as therapeutic agents

Publications (3)

Publication Number Publication Date
NO965260D0 NO965260D0 (no) 1996-12-09
NO965260L true NO965260L (no) 1997-02-06
NO315651B1 NO315651B1 (no) 2003-10-06

Family

ID=26305044

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19965260A NO315651B1 (no) 1994-06-10 1996-12-09 Benzopyraner, farmasöytiske preparater inneholdende disse og deres anvendelse som terapeutiske midler

Country Status (29)

Country Link
US (1) US5760074A (no)
EP (2) EP1114821B1 (no)
JP (2) JP3575767B2 (no)
KR (1) KR100397721B1 (no)
CN (2) CN1234702C (no)
AP (1) AP714A (no)
AT (2) ATE250052T1 (no)
AU (1) AU701060B2 (no)
BG (1) BG63339B1 (no)
BR (1) BR9507980A (no)
CA (1) CA2192480C (no)
CY (1) CY2508B1 (no)
CZ (1) CZ286081B6 (no)
DE (2) DE69531801T2 (no)
DK (2) DK1114821T3 (no)
ES (2) ES2170798T3 (no)
FI (1) FI120686B (no)
HK (2) HK1001286A1 (no)
HU (1) HUT76136A (no)
NO (1) NO315651B1 (no)
NZ (1) NZ287872A (no)
OA (1) OA10593A (no)
PL (1) PL188134B1 (no)
PT (2) PT764157E (no)
RO (1) RO113463B1 (no)
SG (1) SG67930A1 (no)
SI (2) SI1114821T1 (no)
SK (1) SK281456B6 (no)
WO (1) WO1995034545A1 (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010021780A1 (en) * 1992-12-11 2001-09-13 Smithkline Beecham P.L.C. Pharmaceutical composition containing bicyclic type compounds
GB9411635D0 (en) * 1994-06-10 1994-08-03 Smithkline Beecham Plc Novel treatment
US6492415B2 (en) * 1996-09-18 2002-12-10 Smithkline Beecham P.L.C. Use of benzopyranols to treat neurological disorders
GB9619492D0 (en) * 1996-09-18 1996-10-30 Smithkline Beecham Plc Novel treatment
GB9726543D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel compositions
GB9813949D0 (en) * 1998-06-29 1998-08-26 Smithkline Beecham Plc Novel compounds
GB0028697D0 (en) * 2000-11-23 2001-01-10 S P A Novel process
RU2413510C2 (ru) * 2005-04-04 2011-03-10 Такеда Фармасьютикал Компани Лимитед Профилактический или терапевтический агент против депрессии или тревожного расстройства
JP2011522031A (ja) * 2008-06-05 2011-07-28 ミンスター・リサーチ・リミテッド 新規な治療
CA2726878A1 (en) * 2008-06-05 2009-12-10 Minster Research Limited Novel treatments
AU2010325755A1 (en) 2009-12-03 2012-06-21 Proximagen Ltd Treatment of infectious diseases
RU2012124837A (ru) * 2009-12-03 2014-01-10 Проксимэджен ЛТД Лечение аллодинии и гипералгезии
CA2877578A1 (en) 2012-07-03 2014-01-09 Proximagen Limited Pro-drug compounds
GB201304814D0 (en) * 2013-03-15 2013-05-01 Proximagen Ltd Pro-drug compounds
GB201322932D0 (en) * 2013-12-23 2014-02-12 Proximagen Ltd Pro-drug compounds
GB201322934D0 (en) 2013-12-23 2014-02-12 Proximagen Ltd Prodrug compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3479726D1 (de) * 1983-05-18 1989-10-19 Beecham Group Plc Benzopyran derivatives.
GB9112721D0 (en) * 1991-06-13 1991-07-31 Smithkline Beecham Plc Novel treatment
DE69327965T2 (de) * 1992-12-11 2000-10-19 Smithkline Beecham Plc Pharmazeutische zusammenstellung enthaltende bizyklisch typ verbindungen
EP0673373A1 (en) * 1992-12-11 1995-09-27 Smithkline Beecham Plc Bicyclic compounds with pharmaceutical activity
US5536718A (en) * 1995-01-17 1996-07-16 American Cyanamid Company Tricyclic benzazepine vasopressin antagonists

Also Published As

Publication number Publication date
AU701060B2 (en) 1999-01-21
FI964936A0 (fi) 1996-12-10
NO965260D0 (no) 1996-12-09
DE69524871T2 (de) 2002-08-22
ES2207590T3 (es) 2004-06-01
CA2192480C (en) 2007-07-24
JP3575767B2 (ja) 2004-10-13
JPH10501251A (ja) 1998-02-03
FI964936A (fi) 1997-02-06
HK1001286A1 (en) 1998-06-12
DE69531801D1 (de) 2003-10-23
FI120686B (fi) 2010-01-29
DE69531801T2 (de) 2004-07-01
SG67930A1 (en) 1999-10-19
AP9600889A0 (en) 1997-01-31
BR9507980A (pt) 1997-08-12
CZ361796A3 (en) 1997-08-13
ATE250052T1 (de) 2003-10-15
DK0764157T3 (da) 2002-04-22
DE69524871D1 (de) 2002-02-07
SI0764157T1 (en) 2002-06-30
NO315651B1 (no) 2003-10-06
BG63339B1 (bg) 2001-10-31
RO113463B1 (ro) 1998-07-30
EP0764157A1 (en) 1997-03-26
CY2508B1 (en) 2005-12-23
EP0764157B1 (en) 2002-01-02
AP714A (en) 1998-12-23
CZ286081B6 (cs) 2000-01-12
CN1234702C (zh) 2006-01-04
CN1154698A (zh) 1997-07-16
DK1114821T3 (da) 2004-02-02
CA2192480A1 (en) 1995-12-21
AU2672795A (en) 1996-01-05
CN1336369A (zh) 2002-02-20
WO1995034545A1 (en) 1995-12-21
NZ287872A (en) 1998-05-27
PT764157E (pt) 2002-06-28
EP1114821A1 (en) 2001-07-11
HK1039115A1 (en) 2002-04-12
JP2003238554A (ja) 2003-08-27
HU9603415D0 (en) 1997-02-28
HK1039115B (zh) 2004-08-13
SI1114821T1 (en) 2004-02-29
KR100397721B1 (ko) 2004-04-28
BG101040A (en) 1997-08-29
ATE211469T1 (de) 2002-01-15
SK158796A3 (en) 1997-07-09
SK281456B6 (sk) 2001-03-12
CN1174975C (zh) 2004-11-10
PL188134B1 (pl) 2004-12-31
OA10593A (en) 2002-07-10
EP1114821B1 (en) 2003-09-17
ES2170798T3 (es) 2002-08-16
US5760074A (en) 1998-06-02
HUT76136A (en) 1997-06-30
PT1114821E (pt) 2004-02-27
PL317579A1 (en) 1997-04-14

Similar Documents

Publication Publication Date Title
NO985977D0 (no) Spiro-piperidinderivater og deres anvendelse som terapeutiske midler
DK0906292T3 (da) Triazolylmercaptider og deres anvendelse som mikrobicider
DK0869126T3 (da) Dithiolanderivater, deres fremstilling og deres terapeutiske virkning
NO992806D0 (no) Terapeutiske midler
FI970762A0 (fi) Terapiassa käyttökelpoiset spiroatsabisykliset yhdisteet
DE69526237T2 (de) Chirurgische gesichtsmaske
NO971811D0 (no) Bicykliske tetrahydropyrazolopyridiner og deres anvendelse som legemidler
NO943682D0 (no) Imidazol-4-yl-piperidin-derivater, deres fremstilling og terapeutiske anvendelse
DK1019358T3 (da) 3,3-diarylpropylaminer, deres anvendelse og fremstilling
NO20003067L (no) Antipicornavirus-forbindelser og fremgangsmÕter for deres anvendelse og fremstilling
CY2508B1 (en) Benzopyrans and their use as therapeutic agents
NO984761D0 (no) Aminoisokinoliner og aminotienopyridinderivater og deres anvendelse som antiinflammatoriske midler
NO995513L (no) N-triazolyl-2-indolkarboksamider og deres anvendelse som CCK-
NO985891D0 (no) Substituerte benzamid-derivater og deres anvendelse som antikonvulsjonsmidler
NO962477L (no) Benzamidderivater, deres fremstilling og deres terapautiske anvendelse
NO940130D0 (no) Benzimidazolderivater, fremgangsmaate for deres fremstilling og te rapeutisk anvendelse derav
NO972256D0 (no) O-Benzyloksimeterderivater og deres anvendelse som pesticider
NO955242D0 (no) Piperidinderivater, fremgangsmåte for fremstilling derav og deres terapeutiske anvendelse
NO984921D0 (no) Tienopyridinderivater og deres anvendelse
DK0675681T3 (da) Arylamino-alkoiminoderivater og deres anvendelse som fungicider
NO995966D0 (no) 5-naftalen-1-yl-1,3-dioksan-derivater, deres fremstilling og terapeutisk anvendelse
DK0920312T3 (da) Apoptoseinducerende adamantylderivater og deres anvendelse som anticancermidler
NO920228L (no) Polylaktider, deres fremstilling og anvendelse
NO931065D0 (no) Trifluormetanholdige blandinger og deres anvendelse som drivmiddel
KR940022052U (ko) 쑥뜸 받침대

Legal Events

Date Code Title Description
MK1K Patent expired